I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Kalakonda, Nagesh
94
results:
Search for persons
X
Format
Online (94)
Mediatypes
Articles (Online) (35)
OpenAccess-fulltext (59)
Sorted by: Relevance
Sorted by: Year
?
1
The management of newly diagnosed large B‐cell lymphoma: A ..:
Fox, Christopher P.
;
Chaganti, Sridhar
;
McIlroy, Graham
...
British Journal of Haematology. 204 (2024) 4 - p. 1178-1192 , 2024
Link:
https://doi.org/10.1111/..
?
2
P1138: FIVE-YEAR EFFICACY AND SAFETY OF TAFASITAMAB IN PATI..:
Duell, Johannes
;
Abrisqueta, Pau
;
Andre, Marc
...
HemaSphere. 7 (2023) S3 - p. e4580941 , 2023
Link:
https://doi.org/10.1097/..
?
3
Tafasitamab for patients with relapsed or refractory diffus..:
Duell, Johannes
;
Abrisqueta, Pau
;
Andre, Marc
...
Haematologica. 109 (2023) 2 - p. 553-566 , 2023
Link:
https://doi.org/10.3324/..
?
4
ABCL-450 Five-Year Efficacy and Safety of Tafasitamab in Pa..:
Duell, Johannes
;
Abrisqueta, Pau
;
Andre, Marc
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S433-S434 , 2023
Link:
https://doi.org/10.1016/..
?
5
POSTER: ABCL-450 Five-Year Efficacy and Safety of Tafasitam..:
Duell, Johannes
;
Abrisqueta, Pau
;
Andre, Marc
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S206 , 2023
Link:
https://doi.org/10.1016/..
?
6
Comparison of the Effectiveness and Safety of the Oral Sele..:
Casasnovas, Rene-Olivier
;
Follows, George
;
Zijlstra, Josee M.
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) 1 - p. 24-33 , 2022
Link:
https://doi.org/10.1016/..
?
7
PKCβ Facilitates Leukemogenesis in Chronic Lymphocytic Leuk..:
Hay, Jodie
;
Tarafdar, Anuradha
;
Holroyd, Ailsa K.
...
Cancers. 14 (2022) 23 - p. 6006 , 2022
Link:
https://doi.org/10.3390/..
?
8
The Association between Patient Characteristics and the Eff..:
Zijlstra, Josée M.
;
Follows, George
;
Casasnovas, Rene-Olivier
...
Cancers. 14 (2022) 3 - p. 791 , 2022
Link:
https://doi.org/10.3390/..
?
9
COVID‐19 outcomes in haematopoietic cell transplant recipie..:
Lim, Yeong Jer
;
Khan, Umair
;
Karpha, Indrani
...
eJHaem. 3 (2022) 3 - p. 862-872 , 2022
Link:
https://doi.org/10.1002/..
?
10
Effect of Prior Therapy and Disease Refractoriness on the E..:
Schuster, Michael
;
Zijlstra, Josée
;
Casasnovas, Rene-Olivier
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) 7 - p. 483-494 , 2022
Link:
https://doi.org/10.1016/..
?
11
Survival among patients with relapsed/refractory diffuse la..:
Maerevoet, Marie
;
Zijlstra, Josee M.
;
Follows, George
...
Journal of Hematology & Oncology. 14 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1186/..
?
12
Haematological malignancy and nosocomial transmission are a..:
Bhogal, Talvinder
;
Khan, Umair T.
;
Lee, Rebecca
...
Leukemia & Lymphoma. 62 (2021) 7 - p. 1682-1691 , 2021
Link:
https://doi.org/10.1080/..
?
13
Long-term outcomes from the phase II L-MIND study of tafasi..:
Duell, Johannes
;
Maddocks, Kami J.
;
González-Barca, Eva
...
Haematologica. , 2021
Link:
https://doi.org/10.3324/..
?
14
Kinobead Profiling Reveals Reprogramming of BCR Signaling i..:
Linley, Adam J.
;
Karydis, Laura I.
;
Mondru, Anil K.
...
Clinical Cancer Research. 27 (2021) 20 - p. 5647-5659 , 2021
Link:
https://doi.org/10.1158/..
?
15
Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in..:
Nowakowski, Grzegorz S.
;
Willenbacher, Wolfgang
;
Greil, Richard
...
International Journal of Hematology. 115 (2021) 2 - p. 222-232 , 2021
Link:
https://doi.org/10.1007/..
1-15